.jpg&w=3840&q=100)
1. What is the projected Compound Annual Growth Rate (CAGR) of the Veterinary Pharmacovigilance Market?
The projected CAGR is approximately 12.7%.
Market
Insights
7,500+
Reports delivered globally, covering a wide range of industries and sectors.
2,350+
Clients who trust our expertise and rely on our insights for business decisions.
1,050+
Managed Reports, ensuring seamless updates and premium service.
100%
Satisfied Customers, committed to delivering exceptional value and quality.
Veterinary Pharmacovigilance Market Charting Growth Trajectories 2025-2033: Strategic Insights and Forecasts
Veterinary Pharmacovigilance Market by Solution (Software, Services), by Animal Type (Companion animals, Livestock animals, Other animal types), by Type (In-house, Outsourced), by End-user (Veterinary hospitals, Veterinary companies, Academic & research institutes), by North America (U.S., Canada), by Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), by Asia Pacific (Japan, China, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Rest of Latin America), by Middle East and Africa (South Africa, Saudia Arabia, UAE, Rest of Middle East and Africa) Forecast 2025-2033
Veterinary Pharmacovigilance Market Charting Growth Trajectories 2025-2033: Strategic Insights and Forecasts
Key Insights
The size of the Veterinary Pharmacovigilance Market was valued at USD 814.4 Million in 2023 and is projected to reach USD 1880.64 Million by 2032, with an expected CAGR of 12.7% during the forecast period. The Veterinary Pharmacovigilance Market is centered on identifying, evaluating, comprehending, and avoiding adverse effects or other drug-related issues in animals. It entails overseeing veterinary drugs and their proper usage to guarantee their safety and effectiveness in treating various conditions in pets, livestock, and other animals. This sector offers services such as monitoring after sales, managing risks, evaluating safety, reporting negative events, and ensuring compliance with veterinary drug safety regulations. The rise in knowledge about animal health and the increased significance of pharmacovigilance in upholding veterinary care quality are propelling the market forward. Moreover, the increasing instances of negative drug reactions and the spread of veterinary drugs to different areas are adding to the need for veterinary pharmacovigilance services. The incorporation of digital tools and data analytics is improving pharmacovigilance methods, enabling more effective monitoring and quicker detection of possible risks. Due to increased regulatory attention to drug safety, the market for Veterinary Pharmacovigilance is expected to expand as stakeholders aim to enhance animal health results and guarantee the safe usage of veterinary medications.
Veterinary Pharmacovigilance Market Concentration & Characteristics
The Veterinary Pharmacovigilance Market is characterized by:
- Concentration: A few major players dominate the market, such as Accenture, ArisGlobal, and Ennov.
- Innovation: Continuous advancements in data management and analytical tools drive market growth.
- Regulations: Strict regulations govern the veterinary pharmaceutical industry, influencing market compliance.
- Product Substitutes: Limited availability of substitutes due to complex procedures and specialized knowledge required.
- End-User Concentration: Veterinary hospitals and veterinary companies constitute the primary end users.
- M&A: Market consolidation through mergers and acquisitions is a significant trend.
Veterinary Pharmacovigilance Market Trends
Key market insights include:
- Increased Adoption of Technology: Digital tools enhance data collection and analysis, improving pharmacovigilance efficiency.
- Outsourcing Trend: Veterinary companies increasingly outsource pharmacovigilance tasks to specialized service providers.
- Emerging Markets: Rapidly growing animal health industries in developing countries offer significant opportunities for market expansion.
- Focus on Companion Animals: Rising pet ownership and healthcare expenditure drive growth in the companion animal segment.
- Regulatory Harmonization: Global initiatives to streamline regulations facilitate market access and international collaboration.
Key Region or Country & Segment to Dominate the Market
Key Region: North America currently holds the largest market share in the veterinary pharmacovigilance market. This dominance is attributed to several factors: a robust and well-developed veterinary care infrastructure, stringent regulatory frameworks demanding comprehensive safety monitoring, and a high rate of pet ownership fueling increased demand for animal health products. This translates into greater investment in pharmacovigilance activities within the region.
Dominant Segment: While various segments contribute to the market's growth, services related to pharmacovigilance represent a significant portion. Specifically, services such as safety database implementation, the development of robust PV strategies tailored to veterinary products, and specialized audit risk analysis are in high demand. These services provide crucial expertise to veterinary pharmaceutical companies, ensuring compliance with evolving regulatory landscapes and mitigating potential risks associated with animal health products. The specialized knowledge and compliance support offered by these services are key drivers of their market dominance.
Veterinary Pharmacovigilance Market Product Insights Report Coverage & Deliverables
This comprehensive report provides in-depth insights into the veterinary pharmacovigilance market, offering crucial data and analysis for strategic decision-making. Key areas covered include:
- Precise Market Sizing and Segmentation: Detailed analysis of the market's size, value, and growth trajectory, segmented by product type, service offering, and geographic region.
- Competitive Landscape: In-depth profiles of key market players, highlighting their strengths, weaknesses, strategies, and market share. Analysis of competitive dynamics and emerging trends influencing the landscape.
- Growth Drivers and Challenges: Identification and analysis of key factors driving market growth, along with potential challenges and obstacles impacting expansion. This includes an assessment of regulatory changes, technological advancements, and market trends.
- Regional Market Dynamics: Comprehensive regional analysis, exploring market characteristics and growth potential in key geographic areas worldwide.
- Future Market Forecasts: Reliable projections of market growth and trends, providing valuable insights for investment planning and strategic decision-making.
Veterinary Pharmacovigilance Market Analysis
The veterinary pharmacovigilance market was valued at $602.4 million in 2022. This robust market is projected to experience significant growth, expanding at a Compound Annual Growth Rate (CAGR) of 12.7% from 2023 to 2030. By 2030, the market is anticipated to reach a valuation of $1,812.8 million, reflecting the increasing focus on animal health and safety globally.
Veterinary Pharmacovigilance Market Regional Insights
- North America:
- United States
- Canada
- Europe:
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Other European Countries
- Asia Pacific:
- Japan
- China
- India
- Australia
- South Korea
- Other Asia Pacific Countries
- Latin America:
- Brazil
- Mexico
- Other Latin American Countries
- Middle East and Africa:
- South Africa
- Saudi Arabia
- UAE
- Other Middle East and African Countries
Driving Forces: What's Propelling the Veterinary Pharmacovigilance Market
- Rising animal health concerns and disease prevalence
- Stringent regulatory mandates and compliance requirements
- Advancements in data analytics and technology
- Growing awareness of animal welfare
- Increasing outsourcing trend
Challenges and Restraints in Veterinary Pharmacovigilance Market
- Limited availability of skilled professionals
- High costs associated with pharmacovigilance programs
- Drug resistance and disease evolution
- Ethical considerations in animal testing
Emerging Trends in Veterinary Pharmacovigilance Market
- Artificial intelligence and machine learning applications
- Real-world data and clinical trials using electronic health records
- Internet of Things (IoT) devices for remote monitoring
- Personalized medicine and tailored treatments
- Predictive analytics for early detection and prevention
Market Segmentation: Veterinary Pharmacovigilance
- Solution:
- Software
- Services
- Safety database implementation
- PV strategy & operating model
- Audit risk analysis
- Other consulting services
- Animal Type:
- Companion animals
- Livestock animals
- Other animal types
- Type:
- In-house
- Outsourced
- End-user:
- Veterinary hospitals
- Veterinary companies
- Academic & research institutes
Veterinary Pharmacovigilance Industry News
The European Medicines Agency (EMA) implemented an enhanced pharmacovigilance system for veterinary medicinal products (EVVet) starting in January 2022. This improved system reflects revised regulations and reporting requirements, aiming to strengthen the safety and efficacy monitoring of animal medications across the European Union. This reflects a global trend towards stricter regulatory oversight and improved pharmacovigilance practices in the veterinary sector.
Leading Players in the Veterinary Pharmacovigilance Market
Veterinary Pharmacovigilance Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 12.7% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Rising incidence of zoonotic disease
- 3.2.2 Increasing pet ownership
- 3.2.3 Technological advancement in adverse drug reaction (ADR) reporting systems
- 3.2.4 Growing awareness of animal health
- 3.3. Market Restrains
- 3.3.1 Data security and privacy concerns
- 3.3.2 Limited awareness and education
- 3.4. Market Trends
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Veterinary Pharmacovigilance Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Solution
- 5.1.1. Software
- 5.1.2. Services
- 5.1.2.1. Safety database implementation
- 5.1.2.2. PV strategy & operating model
- 5.1.2.3. Audit risk analysis
- 5.1.2.4. Other consulting services
- 5.2. Market Analysis, Insights and Forecast - by Animal Type
- 5.2.1. Companion animals
- 5.2.2. Livestock animals
- 5.2.3. Other animal types
- 5.3. Market Analysis, Insights and Forecast - by Type
- 5.3.1. In-house
- 5.3.2. Outsourced
- 5.4. Market Analysis, Insights and Forecast - by End-user
- 5.4.1. Veterinary hospitals
- 5.4.2. Veterinary companies
- 5.4.3. Academic & research institutes
- 5.5. Market Analysis, Insights and Forecast - by Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East and Africa
- 5.1. Market Analysis, Insights and Forecast - by Solution
- 6. North America Veterinary Pharmacovigilance Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Solution
- 6.1.1. Software
- 6.1.2. Services
- 6.1.2.1. Safety database implementation
- 6.1.2.2. PV strategy & operating model
- 6.1.2.3. Audit risk analysis
- 6.1.2.4. Other consulting services
- 6.2. Market Analysis, Insights and Forecast - by Animal Type
- 6.2.1. Companion animals
- 6.2.2. Livestock animals
- 6.2.3. Other animal types
- 6.3. Market Analysis, Insights and Forecast - by Type
- 6.3.1. In-house
- 6.3.2. Outsourced
- 6.4. Market Analysis, Insights and Forecast - by End-user
- 6.4.1. Veterinary hospitals
- 6.4.2. Veterinary companies
- 6.4.3. Academic & research institutes
- 6.1. Market Analysis, Insights and Forecast - by Solution
- 7. Europe Veterinary Pharmacovigilance Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Solution
- 7.1.1. Software
- 7.1.2. Services
- 7.1.2.1. Safety database implementation
- 7.1.2.2. PV strategy & operating model
- 7.1.2.3. Audit risk analysis
- 7.1.2.4. Other consulting services
- 7.2. Market Analysis, Insights and Forecast - by Animal Type
- 7.2.1. Companion animals
- 7.2.2. Livestock animals
- 7.2.3. Other animal types
- 7.3. Market Analysis, Insights and Forecast - by Type
- 7.3.1. In-house
- 7.3.2. Outsourced
- 7.4. Market Analysis, Insights and Forecast - by End-user
- 7.4.1. Veterinary hospitals
- 7.4.2. Veterinary companies
- 7.4.3. Academic & research institutes
- 7.1. Market Analysis, Insights and Forecast - by Solution
- 8. Asia Pacific Veterinary Pharmacovigilance Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Solution
- 8.1.1. Software
- 8.1.2. Services
- 8.1.2.1. Safety database implementation
- 8.1.2.2. PV strategy & operating model
- 8.1.2.3. Audit risk analysis
- 8.1.2.4. Other consulting services
- 8.2. Market Analysis, Insights and Forecast - by Animal Type
- 8.2.1. Companion animals
- 8.2.2. Livestock animals
- 8.2.3. Other animal types
- 8.3. Market Analysis, Insights and Forecast - by Type
- 8.3.1. In-house
- 8.3.2. Outsourced
- 8.4. Market Analysis, Insights and Forecast - by End-user
- 8.4.1. Veterinary hospitals
- 8.4.2. Veterinary companies
- 8.4.3. Academic & research institutes
- 8.1. Market Analysis, Insights and Forecast - by Solution
- 9. Latin America Veterinary Pharmacovigilance Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Solution
- 9.1.1. Software
- 9.1.2. Services
- 9.1.2.1. Safety database implementation
- 9.1.2.2. PV strategy & operating model
- 9.1.2.3. Audit risk analysis
- 9.1.2.4. Other consulting services
- 9.2. Market Analysis, Insights and Forecast - by Animal Type
- 9.2.1. Companion animals
- 9.2.2. Livestock animals
- 9.2.3. Other animal types
- 9.3. Market Analysis, Insights and Forecast - by Type
- 9.3.1. In-house
- 9.3.2. Outsourced
- 9.4. Market Analysis, Insights and Forecast - by End-user
- 9.4.1. Veterinary hospitals
- 9.4.2. Veterinary companies
- 9.4.3. Academic & research institutes
- 9.1. Market Analysis, Insights and Forecast - by Solution
- 10. Middle East and Africa Veterinary Pharmacovigilance Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Solution
- 10.1.1. Software
- 10.1.2. Services
- 10.1.2.1. Safety database implementation
- 10.1.2.2. PV strategy & operating model
- 10.1.2.3. Audit risk analysis
- 10.1.2.4. Other consulting services
- 10.2. Market Analysis, Insights and Forecast - by Animal Type
- 10.2.1. Companion animals
- 10.2.2. Livestock animals
- 10.2.3. Other animal types
- 10.3. Market Analysis, Insights and Forecast - by Type
- 10.3.1. In-house
- 10.3.2. Outsourced
- 10.4. Market Analysis, Insights and Forecast - by End-user
- 10.4.1. Veterinary hospitals
- 10.4.2. Veterinary companies
- 10.4.3. Academic & research institutes
- 10.1. Market Analysis, Insights and Forecast - by Solution
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Accenture
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 ArisGlobal
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Azierta Contract Science Support Consulting
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Biologit
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Covetrus Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Ennov
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Indivitrus
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Knoell
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Leon Research
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Medfiles
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 PQE Group
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Sarjen Systems Pvt. Ltd
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.13 Teknofarma
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Financials (Based on Availability)
- 11.2.14 TekroLab
- 11.2.14.1. Overview
- 11.2.14.2. Products
- 11.2.14.3. SWOT Analysis
- 11.2.14.4. Recent Developments
- 11.2.14.5. Financials (Based on Availability)
- 11.2.1 Accenture
List of Figures
- Figure 1: Global Veterinary Pharmacovigilance Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: North America Veterinary Pharmacovigilance Market Revenue (Million), by Solution 2024 & 2032
- Figure 3: North America Veterinary Pharmacovigilance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 4: North America Veterinary Pharmacovigilance Market Revenue (Million), by Animal Type 2024 & 2032
- Figure 5: North America Veterinary Pharmacovigilance Market Revenue Share (%), by Animal Type 2024 & 2032
- Figure 6: North America Veterinary Pharmacovigilance Market Revenue (Million), by Type 2024 & 2032
- Figure 7: North America Veterinary Pharmacovigilance Market Revenue Share (%), by Type 2024 & 2032
- Figure 8: North America Veterinary Pharmacovigilance Market Revenue (Million), by End-user 2024 & 2032
- Figure 9: North America Veterinary Pharmacovigilance Market Revenue Share (%), by End-user 2024 & 2032
- Figure 10: North America Veterinary Pharmacovigilance Market Revenue (Million), by Country 2024 & 2032
- Figure 11: North America Veterinary Pharmacovigilance Market Revenue Share (%), by Country 2024 & 2032
- Figure 12: Europe Veterinary Pharmacovigilance Market Revenue (Million), by Solution 2024 & 2032
- Figure 13: Europe Veterinary Pharmacovigilance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 14: Europe Veterinary Pharmacovigilance Market Revenue (Million), by Animal Type 2024 & 2032
- Figure 15: Europe Veterinary Pharmacovigilance Market Revenue Share (%), by Animal Type 2024 & 2032
- Figure 16: Europe Veterinary Pharmacovigilance Market Revenue (Million), by Type 2024 & 2032
- Figure 17: Europe Veterinary Pharmacovigilance Market Revenue Share (%), by Type 2024 & 2032
- Figure 18: Europe Veterinary Pharmacovigilance Market Revenue (Million), by End-user 2024 & 2032
- Figure 19: Europe Veterinary Pharmacovigilance Market Revenue Share (%), by End-user 2024 & 2032
- Figure 20: Europe Veterinary Pharmacovigilance Market Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe Veterinary Pharmacovigilance Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: Asia Pacific Veterinary Pharmacovigilance Market Revenue (Million), by Solution 2024 & 2032
- Figure 23: Asia Pacific Veterinary Pharmacovigilance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 24: Asia Pacific Veterinary Pharmacovigilance Market Revenue (Million), by Animal Type 2024 & 2032
- Figure 25: Asia Pacific Veterinary Pharmacovigilance Market Revenue Share (%), by Animal Type 2024 & 2032
- Figure 26: Asia Pacific Veterinary Pharmacovigilance Market Revenue (Million), by Type 2024 & 2032
- Figure 27: Asia Pacific Veterinary Pharmacovigilance Market Revenue Share (%), by Type 2024 & 2032
- Figure 28: Asia Pacific Veterinary Pharmacovigilance Market Revenue (Million), by End-user 2024 & 2032
- Figure 29: Asia Pacific Veterinary Pharmacovigilance Market Revenue Share (%), by End-user 2024 & 2032
- Figure 30: Asia Pacific Veterinary Pharmacovigilance Market Revenue (Million), by Country 2024 & 2032
- Figure 31: Asia Pacific Veterinary Pharmacovigilance Market Revenue Share (%), by Country 2024 & 2032
- Figure 32: Latin America Veterinary Pharmacovigilance Market Revenue (Million), by Solution 2024 & 2032
- Figure 33: Latin America Veterinary Pharmacovigilance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 34: Latin America Veterinary Pharmacovigilance Market Revenue (Million), by Animal Type 2024 & 2032
- Figure 35: Latin America Veterinary Pharmacovigilance Market Revenue Share (%), by Animal Type 2024 & 2032
- Figure 36: Latin America Veterinary Pharmacovigilance Market Revenue (Million), by Type 2024 & 2032
- Figure 37: Latin America Veterinary Pharmacovigilance Market Revenue Share (%), by Type 2024 & 2032
- Figure 38: Latin America Veterinary Pharmacovigilance Market Revenue (Million), by End-user 2024 & 2032
- Figure 39: Latin America Veterinary Pharmacovigilance Market Revenue Share (%), by End-user 2024 & 2032
- Figure 40: Latin America Veterinary Pharmacovigilance Market Revenue (Million), by Country 2024 & 2032
- Figure 41: Latin America Veterinary Pharmacovigilance Market Revenue Share (%), by Country 2024 & 2032
- Figure 42: Middle East and Africa Veterinary Pharmacovigilance Market Revenue (Million), by Solution 2024 & 2032
- Figure 43: Middle East and Africa Veterinary Pharmacovigilance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 44: Middle East and Africa Veterinary Pharmacovigilance Market Revenue (Million), by Animal Type 2024 & 2032
- Figure 45: Middle East and Africa Veterinary Pharmacovigilance Market Revenue Share (%), by Animal Type 2024 & 2032
- Figure 46: Middle East and Africa Veterinary Pharmacovigilance Market Revenue (Million), by Type 2024 & 2032
- Figure 47: Middle East and Africa Veterinary Pharmacovigilance Market Revenue Share (%), by Type 2024 & 2032
- Figure 48: Middle East and Africa Veterinary Pharmacovigilance Market Revenue (Million), by End-user 2024 & 2032
- Figure 49: Middle East and Africa Veterinary Pharmacovigilance Market Revenue Share (%), by End-user 2024 & 2032
- Figure 50: Middle East and Africa Veterinary Pharmacovigilance Market Revenue (Million), by Country 2024 & 2032
- Figure 51: Middle East and Africa Veterinary Pharmacovigilance Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 3: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Animal Type 2019 & 2032
- Table 4: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Type 2019 & 2032
- Table 5: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by End-user 2019 & 2032
- Table 6: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Region 2019 & 2032
- Table 7: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 8: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Animal Type 2019 & 2032
- Table 9: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Type 2019 & 2032
- Table 10: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by End-user 2019 & 2032
- Table 11: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: U.S. Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Canada Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 15: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Animal Type 2019 & 2032
- Table 16: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Type 2019 & 2032
- Table 17: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by End-user 2019 & 2032
- Table 18: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 19: Germany Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: UK Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: France Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Italy Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Spain Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Netherlands Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Rest of Europe Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 27: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Animal Type 2019 & 2032
- Table 28: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Type 2019 & 2032
- Table 29: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by End-user 2019 & 2032
- Table 30: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 31: Japan Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: China Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 33: India Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Australia Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: South Korea Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Rest of Asia Pacific Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 38: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Animal Type 2019 & 2032
- Table 39: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Type 2019 & 2032
- Table 40: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by End-user 2019 & 2032
- Table 41: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 42: Brazil Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: Mexico Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Latin America Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 46: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Animal Type 2019 & 2032
- Table 47: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Type 2019 & 2032
- Table 48: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by End-user 2019 & 2032
- Table 49: Global Veterinary Pharmacovigilance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 50: South Africa Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 51: Saudia Arabia Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: UAE Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 53: Rest of Middle East and Africa Veterinary Pharmacovigilance Market Revenue (Million) Forecast, by Application 2019 & 2032
STEP 1 - Identification of Relevant Samples Size from Population Database
STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.
Note* : In applicable scenarios
STEP 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
STEP 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Frequently Asked Questions
2. Which companies are prominent players in the Veterinary Pharmacovigilance Market?
Key companies in the market include Accenture, ArisGlobal, Azierta Contract Science Support Consulting, Biologit, Covetrus, Inc., Ennov, Indivitrus, Knoell, Leon Research, Medfiles, PQE Group, Sarjen Systems Pvt. Ltd, Teknofarma, TekroLab.
3. What are the main segments of the Veterinary Pharmacovigilance Market?
The market segments include Solution, Animal Type, Type, End-user.
4. Can you provide details about the market size?
The market size is estimated to be USD 814.4 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising incidence of zoonotic disease. Increasing pet ownership. Technological advancement in adverse drug reaction (ADR) reporting systems. Growing awareness of animal health.
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
Data security and privacy concerns. Limited awareness and education.
8. Can you provide examples of recent developments in the market?
In January 2022, EMA launched an improved pharmacovigilance system for veterinary medicinal products. EVVet amended in line with the veterinary medicinal products regulation and comply with the reporting requirements developed by the veterinary conference on harmonization (VICH). This helped the regulatory bodies in better regulation of veterinary medicinal products.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4,850, USD 5,350, and USD 8,350 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Veterinary Pharmacovigilance Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Veterinary Pharmacovigilance Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Veterinary Pharmacovigilance Market?
To stay informed about further developments, trends, and reports in the Veterinary Pharmacovigilance Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Related Reports
See the similar reports
About Market Insights Report
Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.
Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.